Impact of genotype and phenotype on cardiac biomarkers in patients with transthyretin amyloidosis - Report from the Transthyretin Amyloidosis Outcome Survey (THAOS)

Cardiac troponins and natriuretic peptides are established for risk stratification in light-chain amyloidosis. Data on cardiac biomarkers in transthyretin amyloidosis (ATTR) are lacking. Patients (n = 1617) with any of the following cardiac biomarkers, BNP (n = 1079), NT-proBNP (n = 550), troponin T...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	PloS one 2017-04, Vol.12 (4), p.e0173086-e0173086
Hauptverfasser:	Kristen, Arnt V, Maurer, Mathew S, Rapezzi, Claudio, Mundayat, Rajiv, Suhr, Ole B, Damy, Thibaud
Format:	Artikel
Sprache:	eng
Schlagworte:	Age Amyloid Neuropathies, Familial - genetics Amyloid Neuropathies, Familial - physiopathology Amyloidogenesis Amyloidosis Bioindicators Biological markers Biology and Life Sciences Biomarkers Biomarkers - blood Brain Brain natriuretic peptide Breast cancer Calcium-binding protein Cardiology Cardiomyopathy Coronary artery disease Data collection Data processing Demography Ethics Fibrils Genotype Genotypes Health aspects Heart attacks Heart diseases Heart failure Humans Laboratories Light chains Liver Liver transplantation Liver transplants Medical personnel Medical prognosis Medicine and Health Sciences Mutants Mutation Myocardial infarction Natriuretic Peptide, Brain - blood Natriuretic peptides Peptides Phenotype Population Public health Review boards Risk factors Skin Surveys and Questionnaires Transplantation Troponin I - blood Troponin T - blood Ventricle β-Amyloid
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!